{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:04:46Z","timestamp":1782601486826,"version":"3.54.5"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,12,16]],"date-time":"2012-12-16T00:00:00Z","timestamp":1355616000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oral Maxillofac Surg"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1007\/s10006-012-0379-9","type":"journal-article","created":{"date-parts":[[2012,12,15]],"date-time":"2012-12-15T07:07:19Z","timestamp":1355555239000},"page":"303-306","source":"Crossref","is-referenced-by-count":37,"title":["Osteonecrosis of the mandible due to anti-angiogenic agent, bevacizumab"],"prefix":"10.1007","volume":"17","author":[{"given":"Daria","family":"Pakosch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Papadimas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Munding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darafsch","family":"Kawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus Stephan","family":"Kriwalsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,12,16]]},"reference":[{"key":"379_CR1","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/07357900802208608","volume":"27","author":"JB Aragon-Ching","year":"2009","unstructured":"Aragon-Ching JB, Ning YM, Chen CC, Latham L, Guadagnini JP, Gulley JL, Arlen PM, Wright JJ, Parnes H, Figg WD, Dahut WL (2009) Higher incidence of osteonecrosis of the jaw (ONJ) in patients with metastatic castration resistant prostate cancer treated with anti-angiogenic agents. Cancer Invest 27:221\u2013226","journal-title":"Cancer Invest"},{"key":"379_CR2","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","volume":"61","author":"RE Marx","year":"2003","unstructured":"Marx RE (2003) Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61:1115\u20131117","journal-title":"J Oral Maxillofac Surg"},{"key":"379_CR3","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1016\/j.oraloncology.2011.07.030","volume":"48","author":"U Disel","year":"2012","unstructured":"Disel U, Be\u015fen AA, \u00d6zyilkan \u00d6, Er E, Canpolat T (2012) A case report of bevacizumab-related osteonecrosis of the jaw: old problem, new culpit. Oral Oncol 48:e2\u2013e3","journal-title":"Oral Oncol"},{"key":"379_CR4","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.clbc.2011.02.001","volume":"11","author":"N Ngamphaiboon","year":"2011","unstructured":"Ngamphaiboon N, Frustino JL, Kossoff EB, Sulllivan MA, O\u2019Connor TL (2011) Osteonecrosis of the jaw: dental outcomes in metastatic breast cancer patients treated with bisphosphonates with\/without bevacizumab. Clin Breast Cancer 11:252\u2013257","journal-title":"Clin Breast Cancer"},{"key":"379_CR5","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.tripleo.2010.04.049","volume":"110","author":"S Hoefert","year":"2010","unstructured":"Hoefert S, Eufinger H (2010) Sunitinib may raise the risk of bisphosphonate-related osteonecrosis of the jaw: presentation of three cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 110:463\u2013469","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"379_CR6","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.joms.2011.02.104","volume":"70","author":"RN Hopp","year":"2012","unstructured":"Hopp RN, Pucci J, Santos-Silva AR, Jorge J (2012) Osteonecrosis after administration of intravitreous bevacizumab. J Oral Maxillofac Surg 70:632\u2013635","journal-title":"J Oral Maxillofac Surg"},{"key":"379_CR7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10549-010-0866-3","volume":"122","author":"V Guarneri","year":"2010","unstructured":"Guarneri V, Miles D, Robert N, Dieras V, Glaspy J, Smith I, Thomssen C, Biganzoli L, Taran T, Conte P (2010) Bevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer. Breast Cancer Res Treat 122:181\u2013188","journal-title":"Breast Cancer Res Treat"},{"key":"379_CR8","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ijom.2011.12.016","volume":"41","author":"RE Marx","year":"2012","unstructured":"Marx RE, Tursun R (2012) Suppurative osteomyelitis bisphosphonate induced osteonecrosis, osteoradionecrosis: a blinded histopathologic comparison and its implications for the mechanism of each disease. Int J Oral Maxillofac Surg 41:283\u2013289","journal-title":"Int J Oral Maxillofac Surg"},{"key":"379_CR9","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1093\/annonc\/mdl163","volume":"17","author":"G Sanna","year":"2006","unstructured":"Sanna G, Preda L, Bruschini R, Cossu Rocca M, Ferretti S, Adamoli L, Verri E, Franceschelli L, Goldhirsch A, Nol\u00e8 F (2006) Bisphosphonates and jaw osteonecrosis in patients with advanced breast cancer. Ann Oncol 17:1512\u20131516","journal-title":"Ann Oncol"},{"key":"379_CR10","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jcms.2011.05.003","volume":"40","author":"S Otto","year":"2012","unstructured":"Otto S, Schreyer C, Hafner S, Mast G, Ehrenfeld M, St\u00fcrzenbaum S, Pautke C (2012) Bisphosphonate-related osteonecrosis of the jaws\u2014characteristics, risk factors, clinical features, localization and impact on oncological treatment. J Craniomaxillofac Surg 40:303\u2013309","journal-title":"J Craniomaxillofac Surg"},{"key":"379_CR11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000201931","volume":"76","author":"C Christodoulou","year":"2009","unstructured":"Christodoulou C, Pervena A, Klouvas G, Galani E, Falagas ME, Tsakalos G, Visvikis A, Nikolakopoulou A, Acholos V, Karapanagiotidis G, Batziou E, Skarlos DV (2009) Combination of bisphosphonate and antiangiogenic factors induces osteonecrosis of the jaw more frequently than bisphosphonates alone. Oncology 76:209\u2013211","journal-title":"Oncology"},{"key":"379_CR12","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1200\/JCO.2007.15.5424","volume":"26","author":"CL Estilo","year":"2008","unstructured":"Estilo CL, Fornier M, Farooki A, Carlson D, Bohle G, Huryn JM (2008) Osteonecrosis of the jaw related to bevacizumab. J Clin Oncol 26:4037\u20134038","journal-title":"J Clin Oncol"},{"key":"379_CR13","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1634\/theoncologist.11-10-1070","volume":"11","author":"TT Traina","year":"2006","unstructured":"Traina TT, Norton L, Drucker K, Singh B (2006) Nasal septum perforation in a bevacizumab-treated patient with metastatic breast cancer. Oncologist 11:1070\u20131071","journal-title":"Oncologist"}],"container-title":["Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10006-012-0379-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10006-012-0379-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10006-012-0379-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T03:06:41Z","timestamp":1559099201000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10006-012-0379-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,16]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["379"],"URL":"https:\/\/doi.org\/10.1007\/s10006-012-0379-9","relation":{},"ISSN":["1865-1550","1865-1569"],"issn-type":[{"value":"1865-1550","type":"print"},{"value":"1865-1569","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,16]]}}}